These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16603720)

  • 41. Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis.
    Barter PJ; Brewer HB; Chapman MJ; Hennekens CH; Rader DJ; Tall AR
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):160-7. PubMed ID: 12588754
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of Cholesteryl Ester Transfer Protein Increases Macrophage-Derived Foam Cell Accumulation in Atherosclerotic Lesions of Transgenic Rabbits.
    Gao S; Wang X; Cheng D; Li J; Li L; Ran L; Zhao S; Fan J; Liu E
    Mediators Inflamm; 2017; 2017():3824276. PubMed ID: 29317793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The cholesterolaemic effects of dietary fats in cholesteryl ester transfer protein transgenic mice.
    Chang CK; Snook JT
    Br J Nutr; 2001 Jun; 85(6):643-8. PubMed ID: 11430767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL.
    Serdyuk AP; Morton RE
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):718-26. PubMed ID: 10073979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis.
    El Bouhassani M; Gilibert S; Moreau M; Saint-Charles F; Tréguier M; Poti F; Chapman MJ; Le Goff W; Lesnik P; Huby T
    J Biol Chem; 2011 May; 286(19):17227-38. PubMed ID: 21454568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice.
    Marotti KR; Castle CK; Murray RW; Rehberg EF; Polites HG; Melchior GW
    Arterioscler Thromb; 1992 Jun; 12(6):736-44. PubMed ID: 1591233
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decrease in plasma low-density lipoprotein cholesterol, apolipoprotein B, cholesteryl ester transfer protein, and oxidized low-density lipoprotein by plant stanol ester-containing spread: a randomized, placebo-controlled trial.
    Homma Y; Ikeda I; Ishikawa T; Tateno M; Sugano M; Nakamura H
    Nutrition; 2003 Apr; 19(4):369-74. PubMed ID: 12679174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db/db mice.
    MacLean PS; Bower JF; Vadlamudi S; Osborne JN; Bradfield JF; Burden HW; Bensch WH; Kauffman RF; Barakat HA
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1412-5. PubMed ID: 12791674
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.
    Zhang J; Niimi M; Yang D; Liang J; Xu J; Kimura T; Mathew AV; Guo Y; Fan Y; Zhu T; Song J; Ackermann R; Koike Y; Schwendeman A; Lai L; Pennathur S; Garcia-Barrio M; Fan J; Chen YE
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1068-1075. PubMed ID: 28428219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.
    Hayek T; Chajek-Shaul T; Walsh A; Agellon LB; Moulin P; Tall AR; Breslow JL
    J Clin Invest; 1992 Aug; 90(2):505-10. PubMed ID: 1644921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver.
    Bighetti EJ; Patrício PR; Casquero AC; Berti JA; Oliveira HC
    Lipids Health Dis; 2009 Nov; 8():50. PubMed ID: 19930639
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cholesteryl ester transfer protein: an enigmatic protein.
    Moulin P
    Horm Res; 1996; 45(3-5):238-44. PubMed ID: 8964591
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Remodelling of lipoproteins in transgenic mice expressing human cholesteryl ester transfer protein.
    Dinchuk J; Hart J; Gonzalez G; Karmann G; Schmidt D; Wirak DO
    Biochim Biophys Acta; 1995 Apr; 1255(3):301-10. PubMed ID: 7734447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atherosclerosis in aged mice over-expressing the reverse cholesterol transport genes.
    Berti JA; de Faria EC; Oliveira HC
    Braz J Med Biol Res; 2005 Mar; 38(3):391-8. PubMed ID: 15761619
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Co-expression of cholesteryl ester transfer protein and defective apolipoprotein E in transgenic mice alters plasma cholesterol distribution. Implications for the pathogenesis of type III hyperlipoproteinemia.
    Fazio S; Marotti KR; Lee YL; Castle CK; Melchior GW; Rall SC
    J Biol Chem; 1994 Dec; 269(51):32368-72. PubMed ID: 7798236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The dual PPARalpha/gamma agonist tesaglitazar blocks progression of pre-existing atherosclerosis in APOE*3Leiden.CETP transgenic mice.
    van der Hoorn JW; Jukema JW; Havekes LM; Lundholm E; Camejo G; Rensen PC; Princen HM
    Br J Pharmacol; 2009 Apr; 156(7):1067-75. PubMed ID: 19220285
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver.
    Gauthier A; Lau P; Zha X; Milne R; McPherson R
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2177-84. PubMed ID: 16123327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.